Visual Information Processing Evaluation and Orthoptic and Vision Therapy – Commercial and Individual Exchange Medical Policyopen_in_new

UnitedHealthcare considers occlusion or pharmacologic penalization for amblyopia, orthoptic/vision therapy for convergence insufficiency, and prism adaptation for esotropia medically necessary, but deems orthoptic/vision therapy for other indications (including learning disabilities, visual information‑processing evaluations, vision restoration after stroke/trauma, and remote/digital amblyopia therapies) unproven and not medically necessary. Coverage is determined by the member’s specific benefit document (plan‑level exclusions may apply), orthoptic/vision therapy excludes refractive treatment, and the policy emphasizes limited/conflicting evidence and that FDA clearance alone does not assure coverage.

"Occlusion Therapy or Pharmacologic Penalization Therapy for treating Amblyopia Orthoptic Therapy or Vision Therapy for treating Convergence Insufficiency Prism Adaptation Therapy for treating Esotr..."